APOL1 and atherosclerosis: Different transgenic murine models expressing human ApoL1 risk alleles have been constructed; however, they are widely used to investigate the impact of ApoL1 on kidney diseases but not atherosclerosis because wild-type mice with overnutrient intervention are still resistant to atherosclerosis.3